The need for rapid cytogenetics in the era of unique therapies for acute myeloid leukemia
Blood Adv
.
2022 Dec 27;6(24):6210-6212.
doi: 10.1182/bloodadvances.2022008000.
Authors
Anjanaa Vijayanarayanan
1
,
Brandon M Shaw
1
,
Kathryn Gibbons
1
,
Kedar V Inamdar
1
,
Philip Kuriakose
2
,
Madhu P Menon
1
3
Affiliations
1
Department of Pathology and Laboratory Medicine, Henry Ford Hospital, Detroit, MI.
2
Division of Hematology and Oncology, Henry Ford Hospital, Detroit, MI.
3
ARUP Laboratories and Department of Pathology, University of Utah School of Medicine, Salt Lake City, UT.
PMID:
35973157
PMCID:
PMC9791310
DOI:
10.1182/bloodadvances.2022008000
No abstract available
MeSH terms
Cytogenetic Analysis
Cytogenetics
Humans
Leukemia, Myeloid, Acute* / diagnosis
Leukemia, Myeloid, Acute* / genetics
Leukemia, Myeloid, Acute* / therapy